Fortis Health Standalone June 2024 Net Sales at Rs 333.40 crore, up 15.34% Y-o-Y
August 07, 2024 / 09:18 IST
Reported Standalone quarterly numbers for Fortis Healthcare are:Net Sales at Rs 333.40 crore in June 2024 up 15.34% from Rs. 289.07 crore in June 2023.
Quarterly Net Profit at Rs. 26.83 crore in June 2024 up 108.31% from Rs. 12.88 crore in June 2023.
EBITDA stands at Rs. 93.37 crore in June 2024 up 41.99% from Rs. 65.76 crore in June 2023.
Fortis Health EPS has increased to Rs. 0.36 in June 2024 from Rs. 0.17 in June 2023.
| Fortis Health shares closed at 501.85 on August 05, 2024 (NSE) and has given 15.29% returns over the last 6 months and 54.94% over the last 12 months. |
| Fortis Healthcare | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'24 | Mar'24 | Jun'23 | | Net Sales/Income from operations | 333.40 | 307.48 | 289.07 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 333.40 | 307.48 | 289.07 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | -- | | Purchase of Traded Goods | 92.07 | 77.36 | 74.39 | | Increase/Decrease in Stocks | 0.34 | 2.62 | 0.83 | | Power & Fuel | -- | -- | -- | | Employees Cost | 49.18 | 46.01 | 50.12 | | Depreciation | 26.03 | 25.85 | 24.80 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 133.87 | 112.19 | 128.57 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 31.91 | 43.45 | 10.36 | | Other Income | 35.43 | 32.50 | 30.60 | | P/L Before Int., Excpt. Items & Tax | 67.34 | 75.95 | 40.96 | | Interest | 16.84 | 18.44 | 23.30 | | P/L Before Exceptional Items & Tax | 50.50 | 57.51 | 17.66 | | Exceptional Items | -- | 32.10 | -- | | P/L Before Tax | 50.50 | 89.61 | 17.66 | | Tax | 23.67 | 21.28 | 4.78 | | P/L After Tax from Ordinary Activities | 26.83 | 68.33 | 12.88 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 26.83 | 68.33 | 12.88 | | Equity Share Capital | 754.96 | 754.96 | 754.96 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 0.36 | 0.90 | 0.17 | | Diluted EPS | 0.36 | 0.90 | 0.17 | | EPS After Extra Ordinary | | Basic EPS | 0.36 | 0.90 | 0.17 | | Diluted EPS | 0.36 | 0.90 | 0.17 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
